RT Journal Article
SR Electronic
T1 Predictive Model with Analysis of the Initial Spread of COVID-19 in India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.02.20088997
DO 10.1101/2020.05.02.20088997
A1 Ghosh, Shinjini
YR 2020
UL http://medrxiv.org/content/early/2020/05/06/2020.05.02.20088997.abstract
AB The Coronavirus Disease 2019 (COVID-19) has currently ravaged through the world, resulting in over three million confirmed cases and over two hundred thousand deaths, a complete change in daily life as we know it, worldwide lock-downs, travel restrictions, as well as heightened hygiene measures and physical distancing. Being able to analyse and predict the spread of this epidemic-causing disease is hence of utmost importance now, especially as it would help in the reasoning behind important decisions drastically affecting countries and their people, as well as in ensuring efficient resource and utility management. However, the needs of the people and specific conditions of the spread are varying widely from country to country. In this article, we have conducted an in-depth analysis of the spread of COVID-19 in India, patient statistics, as well as proposed a mathematical prediction system that has succeeded in predicting the following day’s number of cases with 83% accuracy, ever since the first COVID-19 case was declared in India.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data referred to in the manuscript are open-sourced. https://api.covid19india.org/ https://www.mohfw.gov.in/